Our vision: To provide the means for accessible, fast and effective treatment for brain related disorders

Our aim: To advance treatments and cures of brain related conditions and diseases through technology

Since our inception we have been focusing on reliable methods of delivering drugs and therapeutic devices through the blood brain barrier to where they will do most good. Together with our sister organisation, Wobbly Williams, we stage spectacular and very different events to raise the money required to advance the research that we believe will make the difference.

Bryn Williams set up Funding Neuro as the registered charity to which people can donate after he was diagnosed with Parkinson’s Disease aged 36.

To read Bryn’s story and the history of the charity, which started with Wobbly Williams, please click here.

Our focus for 2016 is delivery of chemotherapy to children with DIPG (Diffuse intrinsic pontine glioma) brain tumours. Using revolutionary technology developed by Professor Steven Gill, the trial’s objective is to deliver chemotherapy to the tumour whilst protecting healthy cells, and to deliver stronger doses than can be taken orally to destroy the tumour.

Learn more about DIPG 

Watch the Sky News coverage on our crowd funding appeal here

It is vitally important for us to raise £900,000 for a DIPG clinical trial, to accelerate drug development and advance the research that professionals strongly believe will make the difference.
You can watch the video here to find out all about it.

If you would like to make a donation by card, please click here to Donate Now!

We have already raised over £710,000 and with your help we can reach our target.

These are some of the very brave children who have been treated by Professor Gill and his team.


Kira Spedale, 12.

Kira, a brave little girl from Chicago, was one of the first children in the world to receive chemotherapy via Professor Gill’s Convection Enhanced Delivery system, for a DIPG brain tumour. The treatment gave Kira those extra precious months of health that enabled her to enjoy time with her family.
The average time for a child to survive a DIPG tumour from diagnosis is 9 months, Kira lived for 17 months.

Read Kira’s story here






waiting for surgery

Daisy Brooks, 6.

On 3rd May 2014 Daisy’s family were given the devastating news that she was suffering from a DIPG brain stem tumour and that she would quite soon begin to slip away.

Read Daisy’s story here









Gughi Grasselini, 5.

Gughi is only 5 and has traveled from Italy to receive Professor Gill’s experimental treatment for a DIPG.

Read Gughi’s story here




Daisy was the first child to have the CED system implanted with a port to allow repeated infusions of chemotherapy. She, along with several other children, has played a huge part in the ongoing journey to find a cure – not only for DIPG but all types of brain tumours and neurological conditions.

Following these treatments the pioneering team from Bristol were then in a position to confidently deliver chemotherapy via the CED system to others.

We are urgently raising the £900,000 the professor needs for a clinical trial so that a further 18 children can be treated as soon as possible, to advance the development of drugs that could cure this terrible condition, giving hope to children like Kira, Daisy and Gughi.